参考文献/References:
[1]Cao W,Chen HD,Yu YW,et al.Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J].Chin Med J (Engl),2021,134(7):783-791.[2]Sung H,Ferlay J,Siegel RL,et al.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J].CA Cancer J Clin,2021,71(3):209-249.[3]张世栋,王菲.上消化道癌术前胃镜活检、CA199检测与ESD术后病理结果比较[J].分子诊断与治疗杂志,2021,13(7):1138-1141.[4]Griffin-Sobel JP.Gastrointestinal Cancers: Screening and Early Detection[J].Semin Oncol Nurs,2017,33(2):165-171.[5]Velazquez EJ,Brindley TD,Shrestha G,et al.Novel monoclonal antibodies against thymidine kinase 1 and their potential use for the immunotargeting of lung, breast and colon cancer cells[J].Cancer Cell Int,2020,20:127.[6]Singh S,Kumar R,Kumar U,et al.Clinical Significance and Role of TK1, CEA, CA 19-9 and CA 72-4 levels in Diagnosis of Colorectal Cancers[J].Asian Pac J Cancer Prev,2020,21(11):3133-3136.[7]Fanelli GN,Scarpitta R,Cinacchi P,et al.Immunohistochemistry for Thymidine Kinase-1 (TK1): A Potential Tool for the Prognostic Stratification of Breast Cancer Patients[J].J Clin Med,2021,10(22):5416.[8]江蓓蕾,鲍扬漪,叶艳.TK1与肿瘤标志物在消化道肿瘤诊断及病理学特征的相关性[J].安徽医科大学学报,2018,53(11):1762-1766.[9]Moriyama J,Oshima Y,Nanami T,et al.Prognostic impact of CEA/CA19-9 at the time of recurrence in patients with gastric cancer[J].Surg Today,2021,51(10):1638-1648.[10]方宏娇,李承慧.胃癌患者血清CA199、CA724及CEA水平与病情严重程度及预后的关系[J].川北医学院学报,2022,37(2):248-251.[11]周平红,钟芸诗,李全林.中国消化道黏膜下肿瘤内镜诊治专家共识(2018版)[J].中华胃肠外科杂志,2018,21(8):841-852.[12]Hacker U,Hoffmeister A,Lordick F.Diagnostik und Therapie des Magenkarzinoms [Gastric Cancer: diagnosis and current treatment strategies][J].Dtsch Med Wochenschr,2021,146(23):1533-1537.[13]Li YT,Tan XY,Huang LN,et al.Research Progress in Immunosuppressive Tumor Microenvironment of Gastrointestinal Cancer[J].Journal of Sichuan University,2022,53(1):7-14.[14]Yogev O,Almeida GS,Barker KT,et al.In Vivo Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis[J].Cancer Res,2019,79(20):5382-5393.[15]McShane R,Arya S,Stewart AJ,et al.Prognostic features of the tumour microenvironment in oesophageal adenocarcinoma[J].Biochim Biophys Acta Rev Cancer,2021,1876(2):188598.[16]Kasprzak A.The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia[J].Int J Mol Sci,2021,22(4):1565.[17]Vultaggio-Poma V,Sarti AC,Di Virgilio F.Extracellular ATP: A Feasible Target for Cancer Therapy[J].Cells,2020,9(11):2496.[18]Anthony CC,Robbins DJ,Ahmed Y,et al.Nuclear Regulation of Wnt/β-Catenin Signaling: It’s a Complex Situation[J].Genes (Basel),2020,11(8):886.[19]Okamura S,Osaki T,Nishimura K,et al.Thymidine kinase-1/CD31 double immunostaining for identifying activated tumor vessels[J].Biotech Histochem,2019,94(1):60-64.[20]Tang Y,Li K,Cai Z,et al.HSP90α combined with AFP and TK1 improved the diagnostic value for hepatocellular carcinoma[J].Biomark Med,2020,14(10):869-878.[21]Ning S,Wei W,Li J,et al.Clinical significance and diagnostic capacity of serum TK1, CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients[J].J Cancer,2018,9(3):494-501.[22]许海周,赵新磊,陆俊杰,等.血清胸苷激酶1和可溶性NKG2D配体与结直肠癌患者预后的关系[J].中华普通外科杂志,2018,33(9):780-782.[23]秦岭,张章,齐志峰,等.血清胸苷激酶1、游离DNA联合检测与晚期胃癌化疗效果及预后的相关性[J].癌症进展,2020,18(12):1240-1243,1247.
相似文献/References:
[1]陆昕昀,仲 骏.消化道肿瘤手术患者照顾者照护知识需求调查及影响因素分析[J].医学信息,2019,32(19):71.[doi:10.3969/j.issn.1006-1959.2019.19.021]
LU Xin-yun,ZHONG Jun.Investigation on the Needs of Caregivers'Care Knowledge and Analysis of Influencing Factors in Patients with Digestive Tract Cancer Surgery[J].Journal of Medical Information,2019,32(06):71.[doi:10.3969/j.issn.1006-1959.2019.19.021]
[2]余海峰,赵冰清,盛冠男.胃上皮异型增生的诊断和治疗[J].医学信息,2020,33(15):50.[doi:10.3969/j.issn.1006-1959.2020.15.017]
YU Hai-feng,ZHAO Bing-qing,SHENG Guan-nan.Diagnosis and Treatment of Gastric Epithelial Dysplasia[J].Journal of Medical Information,2020,33(06):50.[doi:10.3969/j.issn.1006-1959.2020.15.017]
[3]张亚奇,潘明胜,田彦军,等.双氢青蒿素对消化道肿瘤作用及其机制的研究进展[J].医学信息,2023,36(14):173.[doi:10.3969/j.issn.1006-1959.2023.14.038]
ZHANG Ya-qi,PAN Ming-sheng,TIAN Yan-jun,et al.Research Progress on the Function and Mechanism of Dihydroartemisinin in Digestive Tract Tumors[J].Journal of Medical Information,2023,36(06):173.[doi:10.3969/j.issn.1006-1959.2023.14.038]
[4]匡重英.肿瘤标志物CEA、CA-199联合检测在消化道肿瘤诊断中的应用价值[J].医学信息,2025,38(03):138.[doi:10.3969/j.issn.1006-1959.2025.03.027]
KUANG Chongying.Application Value of Combined Detection of Tumor Markers CEA and CA-199 in the Diagnosis of Digestive Tract Tumors[J].Journal of Medical Information,2025,38(06):138.[doi:10.3969/j.issn.1006-1959.2025.03.027]